Impact of molecular medicine on neuropsychiatry: the clinician's perspective.
Clinical neuropsychiatry has traditionally relied on individual practitioner experience or the apprentice-training model for formulating cases and choosing treatment. Scientifically-based diagnostic criteria and treatment algorithms have been lacking in the overlap area between psychiatry and neurology, owing largely to the complexity of this population population. However, the novel application of new molecular technologies is promising to change the care of neuropsychiatric patients. This review will highlight recent advances in molecular medicine pertaining to neuropsychiatry.Introduction
Ryan
J M
JM
University of Rochester Medical Center, Program in Neurobehavioral Therapeutics, Monroe Community Hospital, 435 E. Henrietta Road, Rochester, NY 14620, USA. jmichael_ryan@urmc.rochester.edu
Loy
R
R
Tariot
P N
PN
D018740:Genetic Heterogeneity; D006801:Humans; D001523:Mental Disorders / Q000188:drug therapy / Q000235:genetics*; D008967:Molecular Biology / Q000379:methods*; D009462:Neurology; D010641:Phenotype; D011570:Psychiatry; D016032:Randomized Controlled Trials as Topic